IMS Capital Management’s CME Group CME Stock Holding History

IMS Capital Management’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$1.21M	Sell	4,464 -149	-3%	-$40.5K	0.56%	52
2025 Q2	$1.27M	Buy	4,613 +220	+5%	+$59.8K	0.59%	49
2025 Q1	$1.17M	Buy	4,393 +3	+0.1%	+$740	0.59%	51
2024 Q4	$1.02M	Sell	4,390 -5	-0.1%	-$1.15K	0.47%	57
2024 Q3	$970K	Sell	4,395 -199	-4%	-$41.2K	0.44%	61
2024 Q2	$959K	Sell	4,594 -519	-10%	-$107K	0.45%	59
2024 Q1	$1.1M	Sell	5,113 -332	-6%	-$69.7K	0.51%	53
2023 Q4	$1.15M	Sell	5,445 -135	-2%	-$28.8K	0.56%	48
2023 Q3	$1.12M	Sell	5,580 -51	-0.9%	-$10.1K	0.67%	41
2023 Q2	$1.04M	Sell	5,631 -81	-1%	-$15K	0.58%	45
2023 Q1	$1.09M	Hold	5,712	–	–	0.65%	45
2022 Q4	$961K	Sell	5,712 -425	-7%	-$73.9K	0.61%	48
2022 Q3	$1.09M	Hold	6,137	–	–	0.75%	39
2022 Q2	$1.26M	Buy	6,137 +148	+2%	+$31.4K	0.81%	34
2022 Q1	$1.43M	Sell	5,989 -35	-0.6%	-$8.22K	0.75%	36
2021 Q4	$1.38M	Buy	6,024 +753	+14%	+$166K	0.71%	38
2021 Q3	$1.02M	Buy	5,271 +129	+3%	+$26.1K	0.59%	47
2021 Q2	$1.09M	Sell	5,142 -91	-2%	-$19.2K	0.65%	45
2021 Q1	$1.07M	Sell	5,233 -1,353	-21%	-$266K	0.67%	40
2020 Q4	$1.2M	Sell	6,586 -1,955	-23%	-$332K	0.75%	32
2020 Q3	$1.43M	Buy	8,541 +18	+0.2%	+$3.03K	1.03%	17
2020 Q2	$1.39M	Buy	8,523 +1,984	+30%	+$356K	1.07%	15
2020 Q1	$1.13M	Sell	6,539 -565	-8%	-$112K	1.15%	15
2019 Q4	$1.43M	Sell	7,104 -1,095	-13%	-$225K	0.98%	16
2019 Q3	$1.73M	Buy	8,199 +85	+1%	+$17.8K	1.32%	10
2019 Q2	$1.57M	Hold	8,114	–	–	1.17%	12
2019 Q1	$1.33M	Buy	8,114 +80	+1%	+$14.1K	1.09%	17
2018 Q4	$1.51M	Sell	8,034 -2,230	-22%	-$412K	1.41%	11
2018 Q3	$1.75M	Buy	10,264 +342	+3%	+$57.6K	1.18%	9
2018 Q2	$1.63M	Buy	9,922 +1,050	+12%	+$171K	1.03%	10
2018 Q1	$1.3M	Hold	8,872	–	–	0.8%	19
2017 Q4	$1.3M	Sell	8,872 -754	-8%	-$107K	0.8%	19
2017 Q3	$1.31M	Buy	9,626 +302	+3%	+$38.2K	0.84%	17
2017 Q2	$1.17M	Buy	9,324 +1,124	+14%	+$134K	1.1%	25
2017 Q1	$974K	Buy	8,200 +1,200	+17%	+$144K	0.98%	46
2016 Q4	$807K	Buy	7,000 +950	+16%	+$106K	0.86%	48
2016 Q3	$632K	Buy	6,050 +100	+2%	+$10.4K	0.73%	49
2016 Q2	$580K	Buy	5,950 +300	+5%	+$28.4K	0.68%	53
2016 Q1	$543K	Hold	5,650	–	–	0.66%	51
2015 Q4	$512K	Hold	5,650	–	–	0.63%	59
2015 Q3	$524K	Buy	5,650 +180	+3%	+$17.1K	0.63%	61
2015 Q2	$509K	Buy	5,470 +1,470	+37%	+$137K	0.61%	65
2015 Q1	$379K	Buy	4,000 +600	+18%	+$55.6K	0.42%	81
2014 Q4	$301K	Buy	+3,400	New	+$288K	0.34%	101

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

IMS Capital Management's CME Position: Q3 2025 in Review

IMS Capital Management reduced its CME Group (CME) stake by 3.2% in Q3 2025, selling an estimated $40.5K and leaving 4,464 shares worth $1.21M. The position accounts for 0.56% of the portfolio, ranked #52.

IMS Capital Management first reported a position in CME in Q4 2014 and has held it in 44 quarters since. The position peaked at $1.75M in Q3 2018. 1,651 funds tracked by Wall St. Rank hold CME as of Q3 2025.

IMS Capital Management held 4,464 shares of CME Group worth $1.21M as of Q3 2025.
IMS Capital Management sold 149 CME Group shares in Q3 2025, an estimated $40.5K.
CME Group made up 0.56% of IMS Capital Management's portfolio in Q3 2025, its #52 holding.
IMS Capital Management first reported a position in CME Group in Q4 2014 and has held it in 44 quarters since.
IMS Capital Management's CME Group position peaked at $1.75M in Q3 2018.
1,651 funds tracked by Wall St. Rank held CME Group as of Q3 2025.

Based on IMS Capital Management's 13F filing for Q3 2025, filed 17 Nov 2025.